Discover
ANGO
AngioDynamics, Inc.
16.09
2 x 16.08
1 x 16.10
bid
ask
+
0.34
2.19%
01:31 PM
timesize
| Ytd | 25.35% | |
| 1y | 90.47% |
15.73
day range
16.11
8.45
52 week range
16.11
| Open | 15.78 | Prev Close | 15.75 | Low | 15.73 | High | 16.11 | Mkt Cap | 665.45M |
| Vol | 446.63K | Avg Vol | 434.73K | EPS | -0.39 | P/E | -41.28 | Forward P/E | -36.21 |
| Beta | 0.33 | Short Ratio | 2.88 | Inst. Own | 81.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-14 | 50-d Avg | 13.20 | 200-d Avg | 11.89 | 1yr Est | 13.00 |
| Income Statement | |||
| Total Revenue | 86.61M | ||
| Revenues (USD) | 86.61M | ||
| Cost of Revenue | 39.83M | ||
| Gross Profit | 46.77M | ||
| Operating Expenses | 53.04M | ||
| Research and Development Expense | 8.18M | ||
| Selling, General and Administrative Expense | 41.39M | ||
| Operating Income | -6.27M | ||
| Interest Expense | 105.00K | ||
| Income Tax Expense | 370.00K | ||
| Net Income | -11.40M | ||
| Net Income Common Stock | -11.40M | ||
| Net Income Common Stock (USD) | -11.40M | ||
| Consolidated Income | -11.40M | ||
| Earnings per Basic Share | -0.27 | ||
| Earnings per Basic Share (USD) | -0.27 | ||
| Earnings per Diluted Share | -0.27 | ||
| Earning Before Interest & Taxes (EBIT) | -10.93M | ||
| Earning Before Interest & Taxes (USD) | -10.93M | ||
| Weighted Average Shares | 41.70M | ||
| Weighted Average Shares Diluted | 41.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 53.86M | ||
| Cash and Equivalents (USD) | 53.86M | ||
| Trade and Non-Trade Receivables | 48.33M | ||
| Current Assets | 163.39M | ||
| Property, Plant & Equipment Net | 27.10M | ||
| Total Assets | 267.16M | ||
| Current Liabilities | 74.72M | ||
| Total Liabilities | 96.34M | ||
| Accumulated Retained Earnings (Deficit) | -465.94M | ||
| Accumulated Other Comprehensive Income | 7.68M | ||
| Shareholders Equity | 170.83M | ||
| Shareholders Equity (USD) | 170.83M | ||
| Assets Non-Current | 103.77M | ||
| Goodwill and Intangible Assets | 67.21M | ||
| Inventory | 52.44M | ||
| Liabilities Non-Current | 21.62M | ||
| Trade and Non-Trade Payables | 31.51M | ||
| Tax Liabilities | 5.32M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.95M | ||
| Net Cash Flow from Financing | -108.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 16.05M | ||
| Capital Expenditure | -1.27M | ||
| Issuance (Purchase) of Equity Shares | -11.00K | ||
| Issuance (Repayment) of Debt Securities | -97.00K | ||
| Net Cash Flow from Investing | -1.27M | ||
| Net Cash Flow from Operations | 17.45M | ||
| Effect of Exchange Rate Changes on Cash | -20.00K | ||
| Share Based Compensation | 3.92M | ||